Renovacor, Inc.
RCORDelisted Dec 1, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001799850
Renovacor, Inc. was delisted on Dec 1, 2022; its insiders filed their last Form 4 on Apr 5, 2023; 27 institutions reported holding it in 13F filings for Q3 2022, worth $18.4M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Renovacor, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 24 | 24 | 0 |
| Shares | 7.98M | 7.91M | −64.9K (−0.8%) |
| Value | $33.8M | $16.0M | −$17.8M (−52.6%) |
New holders (2)
Institutions that held Renovacor, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bridgeway Capital Management, LLC | 49,900 | $101.0K | 0.00% |
| Murchinson Ltd. | 15,886 | $32.0K | 0.01% |
Sold out (2)
Institutions that held Renovacor, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Kepos Capital LP | 100,000 | $424.0K |
| Royal Bank of Canada | 200 | $1.00K |